MYCN
amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Data
- Doc file
Supplementary Figure 1
- ppt file
Supplementary Figure 2
- tif file